Aktis Oncology (AKTS) stock is given a "Buy" rating, driven by its innovative miniprotein radioconjugates targeting Nectin-4 and B7-H3 solid tumors. Read the full analysis here.
For the current round, conducted digitally, 6,79,238 households were surveyed across states and UTs between 2023 and 2024. The 6th round may provide details about Covid-19 cases, deaths and hospitalisation. Read Full Article →
On Tuesday, Edison Intl (NYSE: EIX ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/ . Access the full call at https://edge.media-server.com/mmc/p/
Community members can provide comment May 5 on the $420 million bond that would fund several station improvements. Read Full Article →
Hindustan Zinc published its Q4FY26 earnings call transcript featuring management discussion on record quarterly performance with 49% revenue growth to ₹13,544 crore and 68% profit growth to ₹5,033 crore. The company achieved lowest-ever cost of production at $903 per tonne and provided comprehensive FY27 guidance with expected mined
